Protier Biotech

Raised $2.3M in a Pre-Series A round, announced 6 April 2026.

Total raised: $2.3M

Latest round Pre-Series ACountry South KoreaSector Health

Round

$2.3MPre-Series A, 6 April 2026

Funds speed preclinical entry of multiple myeloma candidates and expansion to other cancers.

Amount: $2.3M
Stage: Pre-Series A
Announced: 6 April 2026
Lead: Hana Ventures
Other investors: Korea Investment Accelerator, IBK Venture Investment, Mirae Science & Technology Holdings, T Investment
Use of funds: Funds speed preclinical entry of multiple myeloma candidates and expansion to other cancers.
Checked: Amount and date matched across 2 press sources
Sources: Protia Biotech raises 3.5 billion won pre-Series A for molecular glue drugs biospectator.com
Protia Biotech raises 3.5 billion won pre-Series A for molecular glue drugs startuprecipe.co.kr

Company

Develops molecular glue cancer drugs and molecular glue drug conjugates

Based in: Seoul, South Korea
Sector: Health
Website: protierbiotech.com ↗

Questions

How much has Protier Biotech raised?

Protier Biotech raised $2.3M in a Pre-Series A round, announced on 6 April 2026.

Who invested in Protier Biotech?

Hana Ventures led. Investors include Hana Ventures, Korea Investment Accelerator, IBK Venture Investment, Mirae Science & Technology Holdings and T Investment.